Skip to content

Discontinued — last reported Q4 '19

Gross margin at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
76.5%-2.9pp
ALN
Alnylam PharmaceuticalsALNY
81%-5.3pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
95.1%-0.2pp
United Therapeutics logo
United TherapeuticsUTHR
86.6%-2.4pp
Biogen logo
BiogenBIIB
75.5%-0.1pp
LQD
Liquidia CorporationLQDA
58.1%-18.7pp

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$6.55B+40.3%
Enterprise value$6.11B+77.3%
P/E
P/S7.9×+5.3×

Profitability

See full
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%
Debt / equity372.3×
Current ratio2.4×-1.5×

Where this comes from

Calculated from PTC Therapeutics’s reported figures.

Based on trailing twelve months.

The official record: PTC Therapeutics’s 10-K, filed February 25, 2021, on SEC EDGAR. View the filing →

Questions, answered.

What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.